Blood Brain Barrier on a Chip Could Stand in for Children in Paediatric Brain Research

Bethesda, MD (Scicasts) — In the human brain, the BBB is not the Better Business Bureau but the blood brain barrier and the BBB is serious business in human physiology. The human BBB separates circulating blood from the central nervous system, thus protecting the brain from many infections and toxins. But the BBB also blocks the passage of many potentially useful drugs to the brain and it has long stymied scientists who want to learn more about this vital tissue because of the lack of realistic non-human lab models. Even less is known about the BBB in children.

Read more: Blood Brain Barrier on a Chip Could Stand in for Children in Paediatric Brain Research

SynVivo recognized among “Top 10 Innovations of 2013” by The Scientist

HUNTSVILLE, Ala. December 4, 2013 - CFD Research Corporation developed SynVivo® microfluidic cell-based assay platform has been recognized as one of the "Top 10 Innovations of 2013" by The Scientist magazine. SynVivo enables faster, more efficient drug development by combining the control of in vitro testing with the realism of in vivo studies.

Read more: SynVivo recognized among “Top 10 Innovations of 2013” by The Scientist

CFDRC Developing Physiologically Realistic in vitro Tumor Microenvironment Platform

SynVivo-Tumor offers real-time analysis and visualization of drug delivery and cellular interactions and will be showcased at the December ASCB meeting in San Francisco.

HUNTSVILLE, Ala. December 10, 2012 - CFD Research Corporation has been awarded a $1.3M grant from the National Institutes of Health to develop their novel in vitro tumor model. SynVivo-Tumor replicates the tumor microenvironment with physiologically and morphologically realistic microvasculature including endothelial cell-lined leaky vessels and 3D solid tumors.

Read more: CFDRC Developing Physiologically Realistic in vitro Tumor Microenvironment Platform

Join Our Mailinglist